This paper describes a patient who developed diffuse and symmetrical muscle weakness
after a long stay in the intensive care unit (ICU) due to coronavirus disease 2019 (COVID …

Background The COVID‐19 pandemic has greatly increased the incidence and clinical
importance of critical illness myopathy (CIM), because it is one of the most common …

Objective To explore the spectrum of skeletal muscle and nerve pathology of patients who
died after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and to …

This study was conducted to determine the prevalence of prolonged neuromuscular
symptoms, including fatigue, anosmia, headache, myalgia, and joint pain in COVID-19 …

Importance Myalgia, increased levels of creatine kinase, and persistent muscle weakness
have been reported in patients with COVID-19. Objective To study skeletal muscle and …

Background There is limited information about the impact of coronavirus disease (COVID‐
19) on the muscular dysfunction, despite the generalized weakness and fatigue that patients …

COVID-19 is caused by the coronavirus SARS-CoV-2 that has an affinity for neural tissue.
There are reports of encephalitis, encephalopathy, cranial neuropathy, Guillain-Barrè …

Since the coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), a growing body of evidence indicates …

First identified in November 2019 in Hubei Province, the coronavirus disease of 2019
(COVID-19) caused by SARS-CoV-2 soon spread worldwide to become a global health …

Background Post-COVID-19 syndrome is characterized by diverse symptoms and
abnormalities that persist beyond 12 weeks from the onset of acute COVID-19. Severity …